Detalles de la búsqueda
1.
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer.
Pharmacogenomics J
; 19(1): 15-24, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29472587
2.
Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy.
Pharmacogenomics J
; 17(6): 506-514, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27779244
3.
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
Br J Cancer
; 111(9): 1757-64, 2014 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25233397
4.
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.
Br J Cancer
; 104(2): 316-23, 2011 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21157449
5.
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
Br J Cancer
; 99(6): 923-9, 2008 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-19238633
Resultados
1 -
5
de 5
1
Próxima >
>>